Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Coutlée F[au]:

Response. Brisson M et al. J Natl Cancer Inst. (2013)

Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study. Trottier H et al. Papillomavirus Res. (2016)

HLA and KIR Associations of Cervical Neoplasia. Bao X et al. J Infect Dis. (2018)

Search results

Items: 1 to 50 of 199

1.

Acceptability of anal cancer screening tests for women living with HIV in the EVVA study.

Kaufman E, de Castro C, Williamson T, Lessard B, Munoz M, Mayrand MH, Burchell AN, Klein MB, Charest L, Auger M, Marcus V, Coutlée F, de Pokomandy A; EVVA Study Group.

Curr Oncol. 2020 Feb;27(1):19-26. doi: 10.3747/co.27.5401. Epub 2020 Feb 1.

2.

Lubricant Investigation in Men to Inhibit Transmission of HPV Infection (LIMIT-HPV): design and methods for a randomised controlled trial.

Laurie C, El-Zein M, Tota J, Tellier PP, Coutlée F, Franco E, de Pokomandy A; LIMIT-HPV study group.

BMJ Open. 2020 Mar 23;10(3):e035113. doi: 10.1136/bmjopen-2019-035113.

3.

Brief Report: Persistence of Non-Vaccine Oncogenic HPV Genotypes in Quadrivalent HPV-Vaccinated Women Living With HIV.

McClymont E, Coutlée F, Lee M, Albert A, Raboud J, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Yudin MH, Harris M, Wobeser W, Bitnun A, Samson L, Money D; CTN 236 HPV in HIV Study Team.

J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):230-234. doi: 10.1097/QAI.0000000000002258.

PMID:
31917750
4.

Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age.

Malagón T, Louvanto K, Ramanakumar AV, Koushik A, Coutlée F, Franco EL; Biomarkers of Cervical Cancer Risk Study Team.

Gynecol Oncol. 2019 Nov;155(2):245-253. doi: 10.1016/j.ygyno.2019.09.010. Epub 2019 Oct 8.

PMID:
31604665
5.

Latency of tobacco smoking for head and neck cancer among HPV-positive and HPV-negative individuals.

Madathil S, Rousseau MC, Joseph L, Coutlée F, Schlecht NF, Franco E, Nicolau B.

Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32708. [Epub ahead of print]

PMID:
31584196
6.

Vaccination of Young Women Decreases Human Papillomavirus Transmission in Heterosexual Couples: Findings from the HITCH Cohort Study.

Wissing MD, Burchell AN, El-Zein M, Tellier PP, Coutlée F, Franco EL.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1825-1834. doi: 10.1158/1055-9965.EPI-19-0618. Epub 2019 Sep 5.

PMID:
31488413
7.

Exploration of the effect of human papillomavirus (HPV) vaccination in a cohort of pregnant women in Montreal, 2010-2016.

Sarr EHM, Mayrand MH, Coutlée F, Niyibizi J, Laporte L, Monnier P, Carceller AM, Lacroix J, Audibert F, Bédard MJ, Girard I, Brassard P, Fraser WD, Trottier H; HERITAGE study group.

Heliyon. 2019 Aug 14;5(8):e02150. doi: 10.1016/j.heliyon.2019.e02150. eCollection 2019 Aug.

8.

Human Papillomavirus Viral Load and Transmission in Young, Recently Formed Heterosexual Couples.

Wissing MD, Louvanto K, Comète E, Burchell AN, El-Zein M, Rodrigues A, Tellier PP, Coutlée F, Franco EL.

J Infect Dis. 2019 Aug 30;220(7):1152-1161. doi: 10.1093/infdis/jiz238.

PMID:
31063542
9.

Characterization of an HPV33 natural variant with enhanced transcriptional activity suggests a role for C/EBPβ in the regulation of the viral early promoter.

Alvarez J, Gagnon D, Coutlée F, Archambault J.

Sci Rep. 2019 Mar 25;9(1):5113. doi: 10.1038/s41598-019-41102-7.

10.

Persistence of human papillomavirus 16, 18 and 52 variants in Inuit women from Northern Quebec, Canada.

Gauthier B, Cerigo H, Coutlée F, Franco EL, Brassard P.

Int J Circumpolar Health. 2018 Dec;77(1):1556556. doi: 10.1080/22423982.2018.1556556.

11.

Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study.

Malagón T, Louvanto K, Wissing M, Burchell AN, Tellier PP, El-Zein M, Coutlée F, Franco EL.

Lancet Infect Dis. 2019 Mar;19(3):317-326. doi: 10.1016/S1473-3099(18)30655-8. Epub 2019 Feb 10.

12.

Human Papillomavirus Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study: Protocol Describing Design, Methods, and Research Goals.

El-Zein M, Coutlée F, Tellier PP, Roger M, Franco EL, Burchell AN; HITCH Study Group.

JMIR Res Protoc. 2019 Jan 16;8(1):e11284. doi: 10.2196/11284.

13.

Increased risk of oropharyngeal cancers mediated by oral human papillomavirus infection: Results from a Canadian study.

Laprise C, Madathil SA, Schlecht NF, Castonguay G, Soulières D, Nguyen-Tan PF, Allison P, Coutlée F, Hier M, Rousseau MC, Franco EL, Nicolau B.

Head Neck. 2019 Mar;41(3):678-685. doi: 10.1002/hed.25436. Epub 2019 Jan 3.

PMID:
30605251
14.

Assessing the time dependence of prognostic values of cytology and human papillomavirus testing in cervical cancer screening.

Isidean SD, Wang Y, Mayrand MH, Ratnam S, Coutlée F, Franco EL, Abrahamowicz M; CCCaST Study Group.

Int J Cancer. 2019 May 15;144(10):2408-2418. doi: 10.1002/ijc.31970. Epub 2019 Jan 21.

PMID:
30411802
15.

Naturally Occurring Variations Modulate the Activity of the HPV33 Early Promoter and its Affinity for the E2 Transcription Factor.

Alvarez J, Gagnon D, Coutlée F, Archambault J.

Sci Rep. 2018 Oct 9;8(1):15015. doi: 10.1038/s41598-018-33243-y.

16.

HLA and KIR Associations of Cervical Neoplasia.

Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Garland SM, Tabrizi SN, Wentzensen N, Sitas F, Trimble C, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA, Duncan EL, Sun YP, Leo PJ.

J Infect Dis. 2018 Nov 5;218(12):2006-2015. doi: 10.1093/infdis/jiy483.

17.

The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus.

McClymont E, Lee M, Raboud J, Coutlée F, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Harris M, Cohen J, Yudin MH, Wobeser W, Money D; CTN 236 HPV in HIV Study Team.

Clin Infect Dis. 2019 Feb 15;68(5):788-794. doi: 10.1093/cid/ciy575.

PMID:
29985988
18.

Impact of Acetic Acid on HPV Testing Using Hybrid Capture 2.

Pina A, Sauthier P, Coutlée F, Trottier H, Mayrand MH.

J Low Genit Tract Dis. 2018 Oct;22(4):352-354. doi: 10.1097/LGT.0000000000000409.

PMID:
29957658
19.

Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men.

Burger EA, Dyer MA, Sy S, Palefsky JM, de Pokomandy A, Coutlee F, Silverberg MJ, Kim JJ.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):10-19. doi: 10.1097/QAI.0000000000001727.

20.

Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial.

Magnan S, Tota JE, El-Zein M, Burchell AN, Schiller JT, Ferenczy A, Tellier PP, Coutlée F, Franco EL; CATCH Study Group.

Clin Microbiol Infect. 2019 Feb;25(2):210-216. doi: 10.1016/j.cmi.2018.04.012. Epub 2018 Apr 21.

21.

Correction: Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2018 Mar 1;14(3):e1007257. doi: 10.1371/journal.pgen.1007257. eCollection 2018 Mar.

22.

Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study.

Trottier H, Mayrand MH, Coutlée F, Monnier P, Laporte L, Niyibizi J, Carceller AM, Fraser WD, Brassard P, Lacroix J, Francoeur D, Bédard MJ, Girard I, Audibert F.

Papillomavirus Res. 2016 Dec;2:145-152. doi: 10.1016/j.pvr.2016.07.001. Epub 2016 Jul 12.

23.

Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.

Goggin P, Sauvageau C, Gilca V, Defay F, Lambert G, Mathieu-C S, Guenoun J, Comète E, Coutlée F.

Hum Vaccin Immunother. 2018 Jan 2;14(1):118-123. doi: 10.1080/21645515.2017.1385688. Epub 2017 Dec 13.

24.

Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.

Farsi NJ, Rousseau MC, Schlecht N, Castonguay G, Allison P, Nguyen-Tan PF, Souliéres D, Coutlée F, Hier M, Madathil S, Franco EL, Nicolau B.

Carcinogenesis. 2017 Dec 7;38(12):1188-1195. doi: 10.1093/carcin/bgx106.

PMID:
29029021
25.

Estimating HPV DNA Deposition Between Sexual Partners Using HPV Concordance, Y Chromosome DNA Detection, and Self-reported Sexual Behaviors.

Malagón T, Burchell AN, El-Zein M, Guénoun J, Tellier PP, Coutlée F, Franco EL; HITCH Study Group.

J Infect Dis. 2017 Dec 5;216(10):1210-1218. doi: 10.1093/infdis/jix477.

26.

The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.

de Pokomandy A, Kaufman E, de Castro C, Mayrand MH, Burchell AN, Klein M, Charest L, Auger M, Rodrigues-Coutlée S, Coutlée F; EVVA Study Group.

J Infect Dis. 2017 Aug 15;216(4):447-456. doi: 10.1093/infdis/jix273.

PMID:
28931234
27.

Y Chromosome DNA in Women's Vaginal Samples as a Biomarker of Recent Vaginal Sex and Condom Use With Male Partners in the HPV Infection and Transmission Among Couples Through Heterosexual Activity Cohort Study.

Malagón T, Burchell A, El-Zein M, Guénoun J, Tellier PP, Coutlée F, Franco EL; HITCH study group.

Sex Transm Dis. 2018 Jan;45(1):28-34. doi: 10.1097/OLQ.0000000000000688.

28.

Argon plasma coagulation treatment of anal high-grade squamous intraepithelial lesions in men who have sex with men living with HIV: results of a 2-year prospective pilot study.

de Pokomandy A, Rouleau D, Lalonde R, Beauvais C, de Castro C, Coutlée F; Human Immunodeficiency and Papilloma Virus Research Group (HIPVIRG) Study Group.

HIV Med. 2018 Feb;19(2):81-89. doi: 10.1111/hiv.12544. Epub 2017 Aug 23.

29.

Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2017 Aug 14;13(8):e1006866. doi: 10.1371/journal.pgen.1006866. eCollection 2017 Aug. Erratum in: PLoS Genet. 2018 Mar 1;14 (3):e1007257.

30.

Human papillomavirus genotypes and risk of head and neck cancers: Results from the HeNCe Life case-control study.

Laprise C, Madathil SA, Schlecht NF, Castonguay G, Soulières D, Nguyen-Tan PF, Allison P, Coutlée F, Hier M, Rousseau MC, Franco EL, Nicolau B.

Oral Oncol. 2017 Jun;69:56-61. doi: 10.1016/j.oraloncology.2017.03.013. Epub 2017 Apr 10.

PMID:
28559021
31.

Assortativity and Mixing by Sexual Behaviors and Sociodemographic Characteristics in Young Adult Heterosexual Dating Partnerships.

Malagón T, Burchell A, El-Zein M, Tellier PP, Coutlée F, Franco EL; HITCH study group.

Sex Transm Dis. 2017 Jun;44(6):329-337. doi: 10.1097/OLQ.0000000000000612.

32.

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.

Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S.

Prev Med. 2017 May;98:5-14. doi: 10.1016/j.ypmed.2016.11.029. Epub 2017 Feb 6.

PMID:
28279264
33.

Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.

Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S.

Prev Med. 2017 May;98:15-20. doi: 10.1016/j.ypmed.2016.11.030. Epub 2017 Feb 6.

PMID:
28279257
34.

Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results.

Isidean SD, Mayrand MH, Ramanakumar AV, Rodrigues I, Ferenczy A, Ratnam S, Coutlée F, Franco EL; CCCaST Study Group.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):923-929. doi: 10.1158/1055-9965.EPI-16-0705. Epub 2017 Jan 17.

35.

Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination.

Tota JE, Jiang M, Ramanakumar AV, Walter SD, Kaufman JS, Coutlée F, Richardson H, Burchell AN, Koushik A, Mayrand MH, Villa LL, Franco EL.

PLoS One. 2016 Dec 22;11(12):e0166329. doi: 10.1371/journal.pone.0166329. eCollection 2016.

36.

HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.

Money DM, Moses E, Blitz S, Vandriel SM, Lipsky N, Walmsley SL, Loutfy M, Trottier S, Smaill F, Yudin MH, Klein M, Harris M, Cohen J, Wobeser W, Bitnun A, Lapointe N, Samson L, Brophy J, Karatzios C, Ogilvie G, Coutlée F, Raboud J; HPV in HIV Study Group.

Vaccine. 2016 Sep 14;34(40):4799-806. doi: 10.1016/j.vaccine.2016.08.016. Epub 2016 Aug 17.

PMID:
27544584
37.

Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial.

Isidean SD, Mayrand MH, Ramanakumar AV, Gilbert L, Reid SL, Rodrigues I, Ferenczy A, Ratnam S, Coutlée F, Franco EL; CCCaST Study Group.

Int J Cancer. 2016 Dec 1;139(11):2456-66. doi: 10.1002/ijc.30385. Epub 2016 Aug 30.

38.

Cervical Infection With Vaccine-Associated Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections.

Tota JE, Ramanakumar AV, Villa LL, Richardson H, Burchell AN, Coutlée F, Franco EL.

J Infect Dis. 2016 Sep 1;214(5):676-84. doi: 10.1093/infdis/jiw215. Epub 2016 Jun 2.

39.

Human papillomavirus variants among Inuit women in northern Quebec, Canada.

Gauthier B, Coutlée F, Franco EL, Brassard P.

Int J Circumpolar Health. 2015 Dec 9;74:29482. doi: 10.3402/ijch.v74.29482. eCollection 2015.

40.

No role for human papillomavirus infection in oral cancers in a region in southern India.

Laprise C, Madathil SA, Allison P, Abraham P, Raghavendran A, Shahul HP, ThekkePurakkal AS, Castonguay G, Coutlée F, Schlecht NF, Rousseau MC, Franco EL, Nicolau B.

Int J Cancer. 2016 Feb 15;138(4):912-7. doi: 10.1002/ijc.29827. Epub 2015 Sep 14.

41.

HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.

Richardson LA, El-Zein M, Ramanakumar AV, Ratnam S, Sangwa-Lugoma G, Longatto-Filho A, Cardoso MA, Coutlée F, Franco EL; PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium.

Cancer Cytopathol. 2015 Dec;123(12):745-54. doi: 10.1002/cncy.21596. Epub 2015 Jul 31.

42.

Long-Lasting Outbreak of Erythromycin- and Ciprofloxacin-Resistant Campylobacter jejuni Subspecies jejuni From 2003 to 2013 in Men Who Have Sex With Men, Quebec, Canada.

Gaudreau C, Rodrigues-Coutlée S, Pilon PA, Coutlée F, Bekal S.

Clin Infect Dis. 2015 Nov 15;61(10):1549-52. doi: 10.1093/cid/civ570. Epub 2015 Jul 17.

PMID:
26187024
43.

Incidence, persistence, and determinants of human papillomavirus infection in a population of Inuit women in northern Quebec.

Bennett R, Cerigo H, Coutlée F, Roger M, Franco EL, Brassard P.

Sex Transm Dis. 2015 May;42(5):272-8. doi: 10.1097/OLQ.0000000000000272.

PMID:
25868140
44.

Sexual transmission of oral human papillomavirus infection among men.

Dahlstrom KR, Burchell AN, Ramanakumar AV, Rodrigues A, Tellier PP, Hanley J, Coutlée F, Franco EL.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2959-64. doi: 10.1158/1055-9965.EPI-14-0386. Epub 2014 Nov 12.

45.

Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens.

Tota JE, Ramanakumar AV, Villa LL, Richardson H, Burchell AN, Koushik A, Mayrand MH, Coutlée F, Franco EL.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):286-90. doi: 10.1158/1055-9965.EPI-14-0566. Epub 2014 Oct 2.

46.

Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16.

Louvanto K, Franco EL, Ramanakumar AV, Vasiljević N, Scibior-Bentkowska D, Koushik A, Cuzick J, Coutlée F, Lorincz AT; Biomarkers of Cervical Cancer Risk Study Team.

Int J Cancer. 2015 Mar 15;136(6):E638-45. doi: 10.1002/ijc.29196. Epub 2014 Sep 19.

47.

Geographical distribution and risk association of human papillomavirus genotype 52-variant lineages.

Zhang C, Park JS, Grce M, Hibbitts S, Palefsky JM, Konno R, Smith-McCune KK, Giovannelli L, Chu TY, Picconi MA, Piña-Sánchez P, Settheetham-Ishida W, Coutlée F, De Marco F, Woo YL, Ho WC, Wong MC, Chirenje MZ, Magure T, Moscicki AB, Sabol I, Fiander AN, Chen Z, Chan MC, Cheung TH, Burk RD, Chan PK.

J Infect Dis. 2014 Nov 15;210(10):1600-4. doi: 10.1093/infdis/jiu310. Epub 2014 May 30.

48.

Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences.

Jelen MM, Chen Z, Kocjan BJ, Burt FJ, Chan PK, Chouhy D, Combrinck CE, Coutlée F, Estrade C, Ferenczy A, Fiander A, Franco EL, Garland SM, Giri AA, González JV, Gröning A, Heidrich K, Hibbitts S, Hošnjak L, Luk TN, Marinic K, Matsukura T, Neumann A, Oštrbenk A, Picconi MA, Richardson H, Sagadin M, Sahli R, Seedat RY, Seme K, Severini A, Sinchi JL, Smahelova J, Tabrizi SN, Tachezy R, Tohme S, Uloza V, Vitkauskiene A, Wong YW, Zidovec Lepej S, Burk RD, Poljak M.

J Virol. 2014 Jul;88(13):7307-16. doi: 10.1128/JVI.00621-14. Epub 2014 Apr 16.

49.

Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis.

Burchell AN, Rodrigues A, Moravan V, Tellier PP, Hanley J, Coutlée F, Franco EL.

J Infect Dis. 2014 Sep 15;210(6):846-52. doi: 10.1093/infdis/jiu200. Epub 2014 Mar 27.

50.

Determinants of human papillomavirus coinfections among Montreal university students: the influence of behavioral and biologic factors.

Smith MA, Tellier PP, Roger M, Coutlée F, Franco EL, Richardson H.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):812-22. doi: 10.1158/1055-9965.EPI-13-1255. Epub 2014 Feb 25.

Supplemental Content

Loading ...
Support Center